146 related articles for article (PubMed ID: 9685942)
1. Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers.
Muraoka M; Hu Z; Shimokawa T; Sekino S; Kurogoshi R; Kuboi Y; Yoshikawa Y; Takada K
J Control Release; 1998 Mar; 52(1-2):119-29. PubMed ID: 9685942
[TBL] [Abstract][Full Text] [Related]
2. Colon delivery efficiencies of intestinal pressure-controlled colon delivery capsules prepared by a coating machine in human subjects.
Hu Z; Mawatari S; Shimokawa T; Kimura G; Yoshikawa Y; Shibata N; Takada K
J Pharm Pharmacol; 2000 Oct; 52(10):1187-93. PubMed ID: 11092562
[TBL] [Abstract][Full Text] [Related]
3. New preparation method of intestinal pressure-controlled colon delivery capsules by coating machine and evaluation in beagle dogs.
Hu Z; Kimura G; Mawatari S; Shimokawa T; Yoshikawa Y; Takada K
J Control Release; 1998 Dec; 56(1-3):293-302. PubMed ID: 9801452
[TBL] [Abstract][Full Text] [Related]
4. Application of a biomagnetic measurement system (BMS) to the evaluation of gastrointestinal transit of intestinal pressure-controlled colon delivery capsules (PCDCs) in human subjects.
Hu Z; Mawatari S; Shibata N; Takada K; Yoshikawa H; Arakawa A; Yosida Y
Pharm Res; 2000 Feb; 17(2):160-7. PubMed ID: 10751030
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method.
Jeong YI; Ohno T; Hu Z; Yoshikawa Y; Shibata N; Nagata S; Takada K
J Control Release; 2001 Apr; 71(2):175-82. PubMed ID: 11274749
[TBL] [Abstract][Full Text] [Related]
6. Technology to obtain sustained release characteristics of drugs after delivered to the colon.
Hu Z; Kimura G; Ito Y; Mawatari S; Shimokawa T; Yoshikawa H; Yoshikawa Y; Takada K
J Drug Target; 1999; 6(6):439-48. PubMed ID: 10937289
[TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of enTRinsic™ drug delivery technology capsule after intake in fed state: A cross-validation approach using salivary tracer technique in comparison to MRI.
Sager M; Grimm M; Aude P; Schick P; Merdivan S; Hasan M; Kromrey ML; Sivert A; Benameur H; Koziolek M; Tzvetkov MV; Weitschies W
J Control Release; 2019 Nov; 313():24-32. PubMed ID: 31626859
[TBL] [Abstract][Full Text] [Related]
8. Low dose caffeine as a salivary tracer for the determination of gastric water emptying in fed and fasted state: A MRI validation study.
Sager M; Jedamzik P; Merdivan S; Grimm M; Schneider F; Kromrey ML; Hasan M; Oswald S; Kühn J; Koziolek M; Weitschies W
Eur J Pharm Biopharm; 2018 Jun; 127():443-452. PubMed ID: 29602018
[TBL] [Abstract][Full Text] [Related]
9. Combined Application of MRI and the Salivary Tracer Technique to Determine the in Vivo Disintegration Time of Immediate Release Formulation Administered to Healthy, Fasted Subjects.
Sager M; Grimm M; Jedamzik P; Merdivan S; Kromrey ML; Hasan M; Koziolek M; Tzvetkov MV; Weitschies W
Mol Pharm; 2019 Apr; 16(4):1782-1786. PubMed ID: 30821987
[TBL] [Abstract][Full Text] [Related]
10. [Ulcerative colitis--colon delivery of 5-aminosalicylic acid].
Muraoka M; Kimura G; Zhaopeng H; Takada K
Nihon Rinsho; 1998 Mar; 56(3):788-94. PubMed ID: 9549374
[TBL] [Abstract][Full Text] [Related]
11. The development and in vivo evaluation of a colon drug delivery system using human volunteers.
Zimová L; Vetchý D; Muselík J; Štembírek J
Drug Deliv; 2012 Feb; 19(2):81-9. PubMed ID: 22211714
[TBL] [Abstract][Full Text] [Related]
12. Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in beagle dogs.
Takaya T; Ikeda C; Imagawa N; Niwa K; Takada K
J Pharm Pharmacol; 1995 Jun; 47(6):474-8. PubMed ID: 7545751
[TBL] [Abstract][Full Text] [Related]
13. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
[TBL] [Abstract][Full Text] [Related]
14. A dissolution test for a pressure-controlled colon delivery capsule: rotating beads method.
Yoshikawa Y; Hu Z; Kimura G; Murakami M; Yoshikawa H; Takada K
J Pharm Pharmacol; 1999 Sep; 51(9):979-89. PubMed ID: 10528979
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of gastrointestinal transit characteristics of oral patch preparation using caffeine as a model drug in human volunteers.
Eaimtrakarn S; Prasad YV; Puthli SP; Yoshikawa Y; Shibata N; Takada K
Drug Metab Pharmacokinet; 2002; 17(4):284-91. PubMed ID: 15618679
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs.
Niwa K; Takaya T; Morimoto T; Takada K
J Drug Target; 1995; 3(2):83-9. PubMed ID: 7496731
[TBL] [Abstract][Full Text] [Related]
17. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma.
Barakat NS; Al-Suwayeh SA; Taha EI; Bakry Yassin AE
J Drug Target; 2011 Jun; 19(5):365-72. PubMed ID: 20681754
[TBL] [Abstract][Full Text] [Related]
18. Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment.
Dvořáčková K; Rabišková M; Muselík J; Gajdziok J; Bajerová M
Drug Dev Ind Pharm; 2011 Oct; 37(10):1131-40. PubMed ID: 21417619
[TBL] [Abstract][Full Text] [Related]
19. Application of pressure-controlled colon delivery capsule to oral administration of glycyrrhizin in dogs.
Shibata N; Ohno T; Shimokawa T; Hu Z; Yoshikawa Y; Koga K; Murakami M; Takada K
J Pharm Pharmacol; 2001 Apr; 53(4):441-7. PubMed ID: 11341360
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Evaluation of a Gastro-Resistant Enprotect
Grimm M; Rump A; Kromrey ML; Morof F; Dumont C; Jannin V; Tzvetkov MV; Weitschies W
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
